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Quantitative gene expression analysis in renal biopsies: A novel cellular mRNA and the labor intensive techniques re-
protocol for a high-throughput multicenter application. quired for analysis, such as in situ hybridization and
Background. Recent advances in gene expression analysis quantitative reverse transcription-polymerase chain re-may add the quantification of mRNA species in renal biopsies
action (RT-PCR) on microdissected renal compartmentsto routine diagnostic procedures in nephrology.
[5], have precluded wide spread application of mRNAMethods. A systematic evaluation was performed on the rel-
evant steps required to efficiently obtain cDNA from renal biop- analysis. Interest in gene expression analysis has been
sies for high-throughput reverse transcription-polymerase chain fueled by rapid developments in molecular biology that
reaction (RT-PCR) based mRNA quantification. could offer novel approaches in clinical medicine. TheResults. The protocol preserves mRNA integrity by a novel
study of gene expression should provide valuable infor-RNase inhibitor and allows meticulous microdissection fol-
mation about the nature and prognosis of disease pro-lowed by maximal RNA recovery from tissue samples. Reverse
transcription was optimized to give the best yield from minimal cesses. New techniques in mRNA quantification are
starting material. RNA quantity and quality were systematically applicable to routine analysis. The real-time PCR tech-
investigated by real-time RT-PCR and electrophoresis on a nique allows highly accurate template quantificationmicrofluidic system, respectively. The reported procedure of-
from minimal tissue samples [6, 7]. The cDNA arrayfers high RNA preservation and increases the yield of cDNA
technology displays gene expression patterns of thou-significantly compared to former protocols.
Conclusion. The simplicity of biopsy material acquisition com- sands of mRNAs in a single reaction [4]. Moreover, it
bined with the centrally performed processing makes this pro- is now possible to study individual mRNA species in
tocol suitable for a wide spectrum of expression analysis in di- single cells (for example, glomerular podocyte [8]).verse clinical settings.
Reverse transcription-polymerase chain reaction based
approaches have been used in the past for gene expres-
sion analysis of microdissected specimen in human renalPercutaneous biopsy of the kidney has become the gold
disease and animal models [7, 9–15]. Unfortunately, moststandard to establish a diagnosis in renal diseases. Fur-
studies had inherent shortcomings including limitationther, it serves to guide proper management and gives in-
in mRNA quality and quantity, available quantificationformation concerning the extent of injury and the prog-
systems and biopsy population for analysis.nosis of disease [1, 2]. Immunofluorescence and electron
To address these problems, the following strategiesmicroscopy added over the last decades as adjunctive
were employed in this study: Starting from existing meth-techniques to light microscopic analysis represent the
ods [7, 9, 10], a new protocol was systematically designedthree approaches used for routine diagnostic of renal
and evaluated taking advantage of novel developmentsbiopsies [3].
and techniques in the field of gene expression analysis.These techniques evaluate structural changes and de-
RNA preservation was achieved in former studies bytect variations on the protein level. Quantitative analysis
immediate snap freezing in liquid nitrogen and storageof a series of mRNA species would add a new dimension
at80C. Hence, the variation in time to freezing causedto routine biopsy analysis [4]. The rapid degradation of
significant problems in the yield and quality of mRNA.
We used a novel RNase inhibitor that allows efficient
preservation of mRNA during storage and microdissec-Key words: real-time RT-PCR, lab-on-a-chip, RNase inhibitor, RNA
isolation, microdissection. tion. Next, RNA isolation procedures were evaluated.
For minute amounts of starting material, direct RT onReceived for publication April 9, 2001
the cellular lysate without prior RNA isolation has beenand in revised form August 1, 2001
Accepted for publication August 30, 2001 shown to be superior to former isolation techniques [9].
This in situ RT prevents the loss of RNA during isolation, 2002 by the International Society of Nephrology
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but introduces cytoplasmic proteins into RT causing was analyzed using the RNA 6000 LabChip (Agilent Tech-
RNA degradation and RT inhibition. A high throughput nologies, Waldbronn, Germany) on a 2100 Bioanalyzer
RNA isolation technique is now introduced that provides (Agilent Technologies). This system performs electro-
a complete lysis of cells and a significant increase in phoretic separation of total RNA by means of a micro-
cDNA yield. For determination of mRNA levels, the fluidic system [16]. Experiments were performed as de-
real-time RT-PCR technique was found to offer a highly scribed by the manufacturer. The high quality of RNA
accurate quantification of minimal amounts of mRNA was confirmed by circumscribed ribosomal peaks in the
and allowed the quantitative analysis of the RT reaction. electrophoresis read-out, with no additional signals below
RNA integrity from microdissected samples could be the ribosomal bands and no shift to shorter fragments.
determined by a microfluidic system [16]. This systematic
Reverse transcriptionevaluation has produced a novel protocol that combines
a high throughput analysis with reproducibility and clini- If not otherwise stated, RT was performed in a 45 L
cal applicability. volume, containing 9 L buffer, 2 L dithiothreitol (DTT;
both from Life Technologies), 0.9 L 25 mmol/L dNTP
(Amersham Pharmacia, Freiburg, Germany), 1 L RNaseMETHODS
inhibitor (Rnasin; Promega, Mannheim, Germany) andHuman biopsies
0.5 L Microcarrier (Molecular Research Center, Cin-
Human kidney biopsies or renal samples from a tu- cinnati, OH, USA), 1 g random hexamers (2 mg/mL
mor-free part of a nephrectomy specimen were obtained stock; Roche, Mannheim, Germany) and 200 U reverse
from patients after informed consent and with acknowl- transcriptase (Superscript, Life Technologies) for one
edgment of the local ethical committee. The material hour at 42C. No DNase treatment was performed as
was handled as described below following the different cDNA-specific primers are available for most targets,
protocols tested. the contamination by genomic DNA was low (Results
section), and a contamination of the cDNA solution byMurine tissue
DNase may lead to the loss of the template during pro-
For testing species independent steps of the protocol longed storage.
murine renal tissue was used. CD 1 mice were sacrificed
and the kidneys were removed immediately. Further han- Real-time quantitative RT-PCR
dling went along the respective protocols.
Real-time RT-PCR was performed on a TaqMan ABI
7700 Sequence Detection System (PE Biosystems, Wei-Microdissection
terstadt, Germany) using heat-activated TaqDNA poly-Microdissection was performed manually under a ste-
merase (Amplitaq Gold; PE Biosystems). After an initialreomicroscope using two dissection needle holders. If
hold of two minutes at 50C and ten minutes at 95C,not otherwise stated the material was microdissected in
the samples were cycled 40 times at 95C for 15 secondsan ice-cold solution. In previous studies microdissec-
and 60C for 60 seconds. For all quantitative analyses thetion was performed in phosphate-buffered saline (PBS)
cDNA content of each sample was compared with an-with or without vanadyl ribonucleoside complex (VRC)
other sample following the Ct technique [6]. This[9, 17]. For the present study three sets of four isolated
procedure uses the formula A0 /B0  (1  E)(Ct,B–Ct,A),glomeruli were microdissected in PBS with or without
where A0 is the initial copy number of sample A; B0 isVRC (10 mmol/L; Life Technologies, Karlsruhe, Ger-
the initial copy number of sample B; E is the efficiencymany). No significant difference in cDNA yield was
of amplification; Ct,A is the threshold cycle of samplefound comparing the two methods. Threshold cycle (Ct)
A; and Ct,B is the threshold cycle of sample B. Thevalues for glyceraldehyde-3-phosphate dehydrogenase
amplification efficiency was defined as 1, as all analyses(GAPDH) on 1% of the respective cDNA were compa-
were performed during the same run, including controlrable after microdissection in VRC or pure PBS [VRC,
dilution series. Following the formula above, the cDNA30.7  3.5 ( SD); VRC-PBS, 30.6  2.2; quantification
content of sample A compared to sample B was calcu-methods are in the section, “Real-time quantitative RT-
lated by subtracting the mean Ct (triplicates) of samplePCR”). Consequently, microdissection were performed
A from the mean Ct of sample B (Ct). Copies of thein PBS if not otherwise stated. Effective tissue separation
individual transcripts in sample A were defined as 2CTwas verified by nephron segment specific gene expression
copies of transcripts in sample B. Initially, the accuracypattern.
of this approach was tested in 21 samples with different
RNA quality control by microfluid electrophoresis cDNA contents (Ct values for GAPDH 23 to 28, mean
26  1.5 SD). Dilutions were calculated along the aboveTotal RNA was isolation by silica gel columns and di-
luted in 30 L RNase-free water. 2 L of this solution protocol to give an expected Ct value of 28. Real-time
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RT-PCR of the diluted samples gave the predicted Ct
of 28, with a standard deviation below 0.33.
GAPDH and -actin served as housekeeping genes to
assess the overall cDNA content. The following oligonu-
cleotide primers (300 nmol/L) and probes (100 nmol/L)
were used: human Wilms tumor antigen (WT-1; gb X51630,
bp 1155 to 1221), sense primer 5	-AAATGGACAGA
AGGGCAGAGC-3	, antisense primer 5	-GGATGGGC
GTTGTGTGGT-3	, fluorescence labeled probe (FAM)
5	-ACCACAGCACAGGGTACGAGAGCGA-3	; hu-
man Synaptopodin (gb NM 007286, bp 1655 to 1720),
sense primer 5	-CCCAAGGTGACCCCGAAT-3	, anti-
sense primer 5	-CTGCCGCCGCTTCTCA-3	, fluores-
cence labeled probe (FAM) 5	-ACTTGCTGGATCTG
GTACAGACAGCGG-3	, murine GAPDH (gb M 32599,
bp 730 to 836): sense primer 5	-CATGGCCTTCCGT Fig. 1. RNA is protected by storage in RNase inhibitor. Real-time
RT-PCR for GAPDH on renal tissue incubated at different tempera-GTTCCTA-3	, antisense primer 5	-ATGCCTGCTTC
tures with () or without ( ) RNase inhibitor for five days. The RNaseACCACCTTCT-3	, fluorescence labeled probe (VIC)
inhibitor shows a significant RNA protection even at room tempera-
5	-CCCAATGTGTCCGTCGTGGATCTGA-3	. Com- tures. No significant difference is seen between the storage at 20C
and 80C in RNase inhibitor. N  3 for each condition, results aremercially available pre-developed TaqMan reagents
mean  SEM, *P 
 0.05 vs. storage at room temperature withoutwere used for human GAPDH and -actin. Similar am-
RNase inhibitor.
plification efficiencies for all targets were demonstrated
by analyzing serial cDNA dilutions showing a slope value
of log input cDNA amount versus (Ct target A  Ct
target B) of 
0.1. The primers for GAPDH and WT-1 three sets of three to four isolated glomeruli were mi-
crodissected from renal biopsies either stored for sixwere cDNA-specific, not showing any amplification sig-
nal tested on 10,000 copies genomic DNA. All primers months or less than two weeks in RNase inhibitor. No
difference was found in Ct values for GAPDH (28.9 and probes were obtained from PE Biosystems.
1.5 for samples stored for less than 2 weeks and 28.3 
Statistics 0.5 for samples stored for up to 6 months, using 1% of
the respective cDNA).Data are given as mean  SD. Statistical significance
(P
 0.05) was analyzed using ANOVA and the Student RNA degradation can be studied by the analysis of
ribosomal RNA signals in routine gel analysis, but thet test, respectively.
amount of total RNA from microdissected samples is to
small to be visible on a routine gel. To determine the
RESULTS
quality of RNA on samples stored for six months in
Biopsy and storage RNase inhibitor at 20C, a microfluidic system was
employed. Tubulointerstitial fragments (1 mm3) wereTo standardize storage conditions a novel, commer-
cially available RNase inhibitor (RNAlater, Ambion, microdissected from six different renal biopsies and total
RNA isolated as described below. Freshly isolated totalAustin, TX, USA) was evaluated. mRNA stability was
tested in murine renal tissue samples stored at room RNA from tissue culture lysate with circumscribed ribo-
somal RNA bands on a 1% 3[N-morpholino]propanetemperature, 4C, 20C and 80C in PBS or RNase
inhibitor, respectively. After five days the tubulointersti- sulfonic acid (MOPS) gel served as control. All microdis-
sected samples showed intact ribosomal RNA (28S/18Stial tissue was microdissected to samples of 0.1 mm3
and GAPDH levels quantified by real-time RT-PCR. In ratio 2). No signs of RNA degradation as small RNA
fragments, additional peaks below ribosomal bands orPBS, only storage at 80C gave a significant protection
of mRNA, demonstrated by a 10.4 5.5 (SD)-fold higher loss of the overall RNA signal were detected by capillary
electrophoresis (Fig. 2).cDNA yield compared to room temperature (Fig. 1). In
contrast, the RNase inhibitor offered satisfactory mRNA
Microdissectionpreservation even at room temperature (8.4  3.1-fold
compared to PBS). Storage at 20C and 80C was Manual microdissection was performed under a stereo-
microscope. This offers a reliable and fast dissection ofcomparably efficient with a 12.5 3.1 and 14.3 6.7-fold
increase in RNA yield compared to PBS at room temper- glomeruli and tubulointerstitial fragments, as evaluated
by high power phase contrast microscopy and analysis forature, respectively (Fig. 1).
To analyze the long time efficiency of RNA protection nephron segment specific markers by real-time RT-PCR.
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Fig. 3. Analysis of nephron segment-specific mRNA markers in mi-
crodissected samples. Expression of GAPDH and WT-1 determined
in human glomerular () and tubulointerstitial ( ) fragments. The
expression of WT-1, a podocyte marker, is 300-fold higher in the glomer-
ular samples, confirming effective tissue separation by microdissection.
Data are N  10 and 8, respectively; results are mean  SD, *P 

0.05.
Fig. 2. RNA integrity after six months storage in RNase inhibitor. Six
microdissected human tubulointerstitial fragments from renal biopsies
Meticulous microdissection requires a sufficient timewere stored for up to 6 months in RNase inhibitor at 20C, total RNA
isolated by silica gel columns and 6% of the isolated RNA analyzed window. Therefore, mRNA stability was compared be-
by electrophoresis on a microfluidic chip. All six show good preservation tween immediate microdissection and after a 90 minuteof 18 S and 28 S ribosomal RNA band on the gel-like view, comparable
delay in RNase inhibitor at room temperature. Analyzingto control RNA (C). Lmolecular size marker. Drifts due to migration
times were eliminated by alignment of the 18 S band (see [16]). the real-time RT-PCR signal for GAPDH showed no sig-
nificant difference in the cDNA yield between both pro-
cedures (Fig. 4B). The RNase inhibitor allows detailed
and time-consuming microdissection of specific organSamples containing only glomerular structures gave a
structures for mRNA experiments.300-fold higher signal for WT-1, a marker for glomerular
To analyze the total loss of mRNA during microdissec-epithelial cells, than tubulointerstitial samples (Fig. 3).
tion, renal tissue was either directly snap-frozen in liquidFrozen tissue samples suffer membrane damage lead-
nitrogen without microdissection or microdissected eithering to leakage of cytoplasm and RNA. In addition,
in PBS or 100% RNase inhibitor (N  4 each, analyzedRNases can degrade mRNA even in ice-cold PBS. Both
as above). Snap-frozen and RNase inhibitor treated sam-mechanisms could induce a significant loss of mRNA
ples gave comparable cDNA yields, whereas the yieldduring microdissection. To increase the RNA yield we
from samples microdissected in PBS was significantlytested microdissection of murine renal tissue in 100, 80,
reduced (Fig. 4C).60, 40, 20% RNase inhibitor or pure PBS. The duration
for microdissection of tubulointerstitial samples was
Cell lysis and homogenizationstandardized to ten minutes for all solutions. As shown
Several lysis protocols were systematically compared,in Figure 4A, a dose-dependent increase in mRNA was
including lysis in 2% Triton-X 100 combined with freeze-found in solutions containing RNase inhibitor. The mi-
thaw cycles in liquid nitrogen, denaturing lysis buffer,crodissection in 100% RNase inhibitor offered the high-
est yield in cDNA, 60-fold above microdissection in PBS. ultrasound treatment or shredder columns for fragmen-
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tation of microdissected tissue. The highest cDNA yield
was achieved by denaturation of the sample with -mer-
captoethanol and guanidine thiocyanate containing lysis
buffer for ten minutes at room temperature. Tissue frag-
mentation with ultrasound or shredder columns did not
improve the yield (data not shown).
RNA isolation
Using microdissected renal tissue, in situ RT was com-
pared to a silica gel-based isolation protocol (RNeasy-
Mini; Qiagen, Germany) followed by RT of the isolated
total RNA. A 75-fold higher cDNA yield was found after
RNA isolation compared to in situ RT. This technique
gave reproducible RNA yields in more than 1000 RNA
isolations from minimal tissue samples down to a single
human or murine glomerulus.
To test for contaminating genomic DNA total RNA
was isolated from microdissected glomeruli by the above
procedure (N  3). Half of each sample was reverse tran-
scribed, the other half processed without addition of
reverse transcriptase. All samples were analyzed for Sy-
naptopodin, as the respective reagents show similar am-
plification efficiencies on cDNA and genomic DNA. Re-
verse transcribed samples showed Ct values of 25 to 26,
whereas only one not-reverse transcribed sample con-
taining only genomic DNA gave any amplification signal
below cycle 45 (that is, Ct 35). This demonstrates a con-
tamination by genomic DNA below 0.1%.
Reverse transcription
Three different concentrations of random hexanucleo-
tides and reverse transcriptase were tested on 10 ng hu-
man total RNA in 45 L RT volume. As shown in
Figure 5A the highest yield of cDNA was found with
the lowest amount of primer (1 g/45 L). For reverse
transcriptase a concentration of 200 U per reaction was
sufficient. Of note, an interference with real-time PCR
could be observed in reactions containing more than
10% of the above RT mix (data not shown). This could
be circumvented by diluting the RT product 1:10 in Tris
and EDTA (TE) buffer prior to the amplifications.
Linearity of RT reaction was evaluated using fivefold
stitial samples were analyzed at baseline () or after 90 minutes in
RNase inhibitor at room temperature ( ). No difference in the Ct
values was found with cDNA-specific GAPDH primers. (mean 20.1 
1.0. and 19.5  0.6, respectively, N  3 for each condition). (C ) Loss
Fig. 4. Evaluation of microdissection conditions. (A) RNA yield after of mRNA during microdissection in PBS. Renal tissue was either di-
microdissection in RNase inhibitor. Human renal tissue was microdis- rectly snap-frozen in liquid nitrogen () or microdissected in PBS ()
sected in 100, 80, 60, 40, 20, and 0% ice-cold RNase inhibitor (diluted or 100% RNase inhibitor ( ). Direct snap-freezing without microdissec-
in PBS). Bar graphs represent the expression ratio for GAPDH normal- tion and microdissection in RNase inhibitor gave comparable cDNA
ized to the lowest signal detected. A concentration dependent increase yields. Samples microdissected in PBS showed significantly reduced
of RNA yield can be seen. All experiments were performed in duplicate, amounts of cDNA, compared to both snap-frozen and RNase inhibitor
and results are mean  SD; *P 
 0.05. (B) The mRNA is stable during treated samples. Data are N  4 for each condition, results are mean 
microdissection in RNase inhibitor for at least 90 minutes. Tubulointer- SD, and *P 
 0.05.
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Fig. 6. Comparison of the initial and the newly developed protocol for
renal biopsy handling. Both protocols are shown in a schematic over-
view. Abbreviations are: RI, RNase inhibitor; GT, guanidine thiocya-
nate; RT, reverse transcription.
Fig. 5. Evaluation of reverse transcription conditions. (A) Comparison
of different enzyme and random primer concentrations. To optimize
Direct comparison of protocolsthe RT reaction different primer and enzyme concentrations were tested
on 10 ng human total RNA. A decrease of random primer concentration Processing cortical segments of murine renal tissue
showed a 50% increase in cDNA yield determined by real-time RT-
either following the previously described (initial) or thePCR using 200 U RTase. N  2 for each condition, results are mean 
SD (RTase  reverse transcriptase). Symbols are: ( ) 100 U RTase; optimized protocol allowed direct comparison of cDNA
( ) 200 U RTase; () 400 U RTase. (B) Verification of quantitative yield (Fig. 6). Following the initial protocol, tissue was
real time RT-PCR. Linearity of RT reaction was evaluated using fivefold
directly microdissected in PBS, lysed by three freeze–dilutions of human total RNA in a range mirroring the amount found
in microdissected renal material (400, 80, 16, 3, 0.6, and 0.12 ng). After thaw cycles in Triton X-100 and random-primed in situ
RT under the above conditions, RT efficiency was evaluated by quanti- reverse transcribed. In a second set of samples the mate-
fication of GAPDH and -actin via real-time RT-PCR. The six dilutions
rial was harvested and microdissected in 100% RNasewere analyzed by real-time RT-PCR in triplets; the corresponding am-
plification curves for -actin are shown. (RN  fluorescence reporter inhibitor, total RNA isolated using silica gel-based col-
signal minus baseline signal). A stringent correlation of PCR product umns and random-primed reverse transcribed. cDNA
quantity with starting RNA concentration could be shown for both
levels obtained by the two protocols were quantifiedmRNAs (R2  0.98 and 0.95 for GAPDH and -actin, respectively),
indicating linear, quantitative RT over a 3 log range. using GAPDH. A 75  15-fold higher cDNA yield was
obtained with the newly developed protocol as compared
to the initial procedure (N  4, Fig. 7).
dilutions of 400 ng to 120 pg human total RNA, a range
found in microdissected renal samples. After RT under the
DISCUSSIONabove conditions RT efficiency was evaluated by quanti-
Routine gene expression analysis is likely to be intro-fication of GAPDH and -actin via real-time RT-PCR.
duced as a novel instrument in biopsy interpretationA positive correlation of PCR product quantity with start-
[4, 5]. The expectations are that these new tools will adding RNA concentration was found for both templates
quantitative parameters to conventional biopsy diagnos-(R2  0.98 and 0.95, respectively), demonstrating linear-
ity of the RT over a 3 log range (Fig. 5B). tic procedures, thus improving disease classification, prog-
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Using this procedure over 500 biopsies have been sam-
pled, sent to the core facility, and stored for up to eight
months without any observed degradation of RNA.
A significant increase in RNA yield was achieved by the
addition of a new silica gel-based RNA isolation proce-
dure. In previous studies in situ RT without prior RNA
isolation showed a higher yield of cDNA compared to
standard RNA isolation procedures [9]. Consequently,
protocols were established that lacked an aggressive cell
lysis step [9–12]. Such protocols could generate biased
RNA samples by the preferential lysis of superficial cell
layers (such as podocytes from glomeruli). The proce-
dure used in our study combines aggressive cell lysis and
RNA isolation, yields a significant increase in cDNA,
and also minimizes genomic DNA contamination. Eik-
mans et al recently reported reproducible RNA isolation
by the silica gel-based technique using tubulointerstitial
fragments, but not glomeruli with their minute amount
of RNA [17].
Analysis of the reverse transcription showed an in-
creased cDNA yield when the random primer concentra-Fig. 7. Comparison of the initial ( ) with the improved () protocol.
Renal tissue was processed using microdissection in PBS combined with tion in the reaction was decreased. This counterintuitive
in situ RT (initial protocol) or storage and microdissection in RNase observation may be due to an increase in cDNA length
inhibitor, RNA isolation and optimized RT (new protocol). An increase
secondary to fewer binding events of random primersin cDNA yield of 2 log steps was demonstrated. Data are N  4 for
each condition, mean  SD; *P 
 0.05. per mRNA molecule. The resulting longer cDNAs may
serve as more effective templates in RT-PCR.
Finally, the employment of real-time RT-PCR for
mRNA quantification allowed systematic evaluations with
nostic prediction and information concerning the response exquisite sensitivity, using 1% from starting material as
to the different treatments available. First results reported little as one isolated glomerulus. Thus, analyses could
in the diagnosis and classification of hematological dis- be performed on up to 100 targets from microdissected
eases show great promise [18]. glomeruli. In addition, the real-time RT-PCR quantifi-
The introduction of molecular analysis of renal biop- cation could be applied for high-throughput analysis.
sies requires the development of a robust and reproduc- The considerable increase in RNA yield and integrity
ible protocol for tissue processing. Our study performed obtained by the protocol described should be helpful
a systematic evaluation of all relevant steps required to also for extending cDNA microarray analysis to small
obtain cDNA from renal biopsies for gene expression biopsy material. In fact, RNA obtained from microdis-
analysis. Special care was taken to address the critical sected tubulointerstitial compartment could be already
problems of biopsy processing relevant in the setting of sufficient as starting material for highly sensitive expres-
a multicenter study. We were able to establish a protocol sion arrays. However, for microdissected glomeruli or
that not only improves the reproducibility of mRNA single nephron segments a quantitative and reproducible
quantification via the RT-PCR approach, but also in- way to amplify the messages in a truly linear manner
creases the amount of mRNA available for expression will be necessary [21]. Optimal RNA recovery will require
screening analysis. Most of the procedures described for fewer cycles of linear amplification and thereby decrease
renal tissue should also be applicable for other material amplification bias [22]. In the future, the reported proto-
obtained by fine needle biopsy. col may facilitate a screening for molecular markers in
We addressed the loss or degradation of RNA by kidney diseases, whose determination could be added to
testing a new RNase inhibitor [19, 20]. The ability to pathology procedures even on routine formaldehyde-
store and ship tissue in a solution preserving RNA allows fixed renal biopsies [23].
a standardized microdissection in a central core facility. In summary, the protocol presented in this study al-
This approach significantly decreases the workload of the lows the easy processing of renal biopsy material for
participating clinical centers and thereby facilitates patient molecular analysis in diverse clinical settings. It offers a
recruitment. In addition, it adds a further level of security high degree of mRNA protection during transportation
to RNA protection, as an interruption in keeping the and storage and an increased yield and quality of the
cDNA obtained for expression studies. This approachtissue frozen does not lead to an immediate loss of mRNA.
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